Viral interleukin-10-engineered autologous hematopoietic stem cell therapy: a novel gene therapy approach to prevent graft rejection.
D000818:Animals; D001483:Base Sequence; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D016027:Heart Transplantation; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006801:Humans; D008214:Lymphocytes / Q000166:cytology; D008297:Male; D051379:Mice; D008969:Molecular Sequence Data; D015202:Protein Engineering; D011994:Recombinant Proteins / Q000378:metabolism; D016038:Skin Transplantation; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D014764:Viral Proteins / Q000096:biosynthesis / Q000235:genetics* / Q000276:immunology
C066460:BCRF1 protein, Human herpesvirus 4; D011994:Recombinant Proteins; D014764:Viral Proteins